Australia's Monash University has collaboratd with Weill Cornell Medicine, Cornell University’s academic medical institution, to tackle new research projects including mental health, health economics, trauma and burns care, as Monash expands its research and innovation presence in the United States (US).
Bringing together world-leading health and medical researchers, the collaboration will accelerate new solutions to global health challenges.
The collaboration with Weill Cornell Medicine builds on Monash’s growing research and innovation presence in North America, anchored by the establishment of the Monash Boston Hub in Kendall Square, the world’s premier life sciences ecosystem.
Operating from the Cambridge Innovation Centre, the Hub was established last year to connect North American biotech, pharmaceutical, and medtech partners directly with Monash’s research capabilities, translation pipelines, and Australia’s accelerated clinical trial pathways.
Monash University Vice-Chancellor and President Professor Sharon Pickering said, “This collaboration between Monash and Weill Cornell Medicine brings together researchers from two medical research powerhouses in global healthcare to rethink how we deliver patient care, optimise health systems, and mobilise research, giving us the scale to challenge traditional models and accelerate progress on health issues affecting millions of people worldwide.”
Image caption- Monash University Vice-Chancellor and President Professor Sharon Pickering (L) and Weill Cornell Medicine’s Senior Associate Dean of International Affairs and Affiliations Dr Michael G. Stewart
